glp-1 lower cholesterol Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Beyond the Cardiovascular Effects of
Description
Trials (2019) 20:191
Most events included nausea, diarrhoea, and vomiting and were mild to moderate
The study found that A
Combining GLP-1s with other weight loss medications like phentermine requires specific medical oversight
